(Paris:COX), Press Release Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Last patient recruited in the NCX 470 (bimatoprost grenod) Phase 3 Denali clinical trial with topline results expected in Q3 2025 Fourth quarter 2024 Nicox Group revenue of EUR13.7 million Cash of EUR10.7 million as of December 31, 2024, following a EUR5.2 […]
FlexLNG Ltd (“Flex LNG” or the “Company”) will release its unaudited financial results for the fourth quarter of 2024 on Tuesday February 4, 2025, on or about 07:00 CET (1:00 a.m. ET). In connection with the earnings release, a live video webcast will be held at 15:00 CET (9:00 a.m. ET) on the same day.
(NASDAQ:LAES),(NASDAQ:LAESV), Geneva, Switzerland, Jan. 21, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company specializing in Semiconductors, PKI, and Post-Quantum technology hardware and software products today announced that its parent company, WISeKey International Holding (“WISeKey” or the “Company”) (NASDAQ: WKEY; SIX: WIHN), a leading global cybersecurity, AI, and IoT company, in
(SWX:WIHN),(NASDAQ:WKEY), WISeKey Establishes Charity Partnerships to Provide Digital Identities and Financial Inclusion to Over One Billion People DAVOS, Switzerland – January 21, 2025 – WISeKey International Holding (“WISeKey” or the “Company”) (NASDAQ: WKEY; SIX: WIHN), a leading global cybersecurity, AI, and IoT company, today announced a groundbreaking partnership with Abraham House and the Global Financial
(Euronext Amsterdam:PHARM),(NasdaqGM:PHARM),(Euronext Amsterdam:PHARM), Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Board of Directors has nominated Fabrice Chouraqui to become Pharming's new Executive Director and Chief Executive Officer, succeeding Sijmen de Vries. Pharming will nominate Mr. Chouraqui for the appointment as Executive
(Paris:SAN), Opella reaches study milestone for Cialis Paris, January 21, 2025. Opella, Sanofi's Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT) to support the switch of Cialis (tadalafil) from a prescription to an over-the-counter medicine. This decision allows for
DeFinity Markets®, the first full-stack institutional digital asset matching and settlement platform for fiat anddigital assets has become an EY client and completed the EY FinTech growth programme, aimed at supporting the most promising scaling FinTechs in the UK. After a rigorous selection process, participants were invited to engage in sessions and cover crucial topics
Virtus Health's first greenfield embryology and andrology facility in Asia strives to stay at the forefront of reproductive medicine through science, ongoing research, evidence-based personalized care, and accessible fertility education. Virtus Fertility Centre Singapore (VFCS) today celebrates its 10th anniversary, commemorating a decade of contributing research and evidence-based science to support fertility preservation and infertility
SEALSQ, WISeKey and Cybersecurity Tech Accord to Host Quantum Security Roundtable Discussion at Davos GlobeNewswire January 21, 2025 Geneva, Switzerland, Jan. 21, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company specializing in Semiconductors, PKI, and Post-Quantum technology hardware and software products today announced that its parent company, WISeKey International Holding
Report with market evolution powered by AI – The globalonline survey software market size is estimated to grow by USD 6.44 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of about13.6% during the forecast period. Growing demand for real-time data collection and analysisis driving market growth,with a trend